CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,681,876
- in 2 filings, $14.7M under 10b5-1 plans
Net −$14,681,876. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Garber Alan M Director | Grant or award · Deferred Stock Units | +29.27 | $512.44 | $15K | 94.73 |
| 2026-07-15 | Garber Alan M Director | Grant or award · Deferred Stock Units | +31.56 | $475.28 | $15K | 65.46 |
| 2026-05-01 | Garber Alan M Director | Grant or award | +472 | 7,344 | ||
| 2026-05-01 | Garber Alan M Director | Grant or award · Stock Option (Right to Buy) | +1,433 | 1,433 | ||
| 2026-04-15 | Garber Alan M Director | Grant or award · Deferred Stock Units | +33.9 | $442.50 | $15K | 33.9 |
| 2025-05-01 | Garber Alan M Director | Grant or award | +398 | 6,872 | ||
| 2025-05-01 | Garber Alan M Director | Grant or award · Stock Option (Right to Buy) | +1,199 | 1,199 | ||
| 2024-05-01 | Garber Alan M Director | Grant or award · Stock Option (Right to Buy) | +3,142 | 3,142 |
Page 1 of 1 · 8 trades